Publications by authors named "D C Moga"
Introduction: Inflammatory biomarkers, including Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-alpha), play a significant role in influencing stroke outcomes, particularly in the progression of post-stroke disability. While numerous studies have suggested a correlation between elevated levels of these cytokines and poor functional recovery, further investigation is needed to understand their prognostic value in acute ischemic stroke.
Materials And Methods: We conducted a prospective study on 56 patients diagnosed with acute ischemic stroke, evaluating IL-6 and TNF-alpha levels on days 1 and 7 post symptom onset.
Background: Observational studies using real-world data (RWD) can address gaps in knowledge on deprescribing medications but are subject to methodological issues. Limited data exist on the methods employed to use RWD to measure the effects of deprescribing.
Objective: To describe methodological approaches used in observational studies of deprescribing medications in older adults.
The effect of carbapenem-resistant versus carbapenem-susceptible infections on patient outcomes at an academic medical center.
Antimicrob Steward Healthc Epidemiol
October 2024
Objective: We sought to compare patient outcomes between carbapenem-resistant (CRE) and carbapenem-susceptible (CSE) infections at our academic medical center.
Design: We conducted a retrospective cohort study of adult patients with a positive culture of E. coli, E.
Article Synopsis
- * A study analyzed a large group of patients with ischemic stroke to evaluate how men and women differ in receiving recommended medications (statins, antihypertensives, anticoagulants) after discharge and their adherence to these treatments over one year.
- * Results showed that women were prescribed fewer medications and were more likely to be non-adherent compared to men, indicating a need for improved attention to how sex influences stroke treatment and adherence.
Background: MicroRNA-150 (miR-150) plays a critical role in immune regulation and has been implicated in autoimmune diseases like Multiple Sclerosis (MS). This review aims to evaluate miR-150's potential as a biomarker for MS, necessitating this review to consolidate current evidence and highlight miR-150's utility in improving diagnostic accuracy and monitoring disease progression.
Methods: A comprehensive literature search was conducted in databases like PubMed, Scopus, Google Scholar, SciSpace, MDPI and Web of Science, adhering to PRISMA guidelines.